High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina

Archives of Virology

Volumn 149, Issue 8, 2004, Pages 1515-1526

  Chabay, P ^a   De Matteo, E ^a   Merediz, A ^a   Preciado, M V ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 4;

EID: 4043114146     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0311-1     Document Type: Article

References (34)

1. Berger C, McQuain C, Sullivan J, Nadal D, Quesenberry P, Knetch H (1997) The 30 bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis. J Infect Dis 176: 1370-1373
2. Bonnet M, Guinebretiere J, Kremmer E, Grunewald V, Benhamou E, Contesso G (1999) Detection of Epstein Barr Virus in invasive breast cancers. J Nat Cancer Inst 91: 1376-1381
3. Chabay P, De Matteo E, Maglio S, Grinstein S, Preciado MV (2002) Assessment of Epstein Barr virus association with pediatric non-Hodgkin's lymphomas in immunocompetent and in immunocompromised patients in Argentina. Arch Pathol Lab Med 126: 331-335
4. Crawford D (2001) Biology and disease associations of Epstein-Barr virus, Phil Trans R Soc Lond B 356: 461-473
5. Dolcetti R, Zancai P, De Re V, Gloghini A, Bigoni B, Pivetta B, De Vita S, Carbone A, Boiocchi M (1997) Epstein-Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease. Blood 89: 1723-1731
6. D'Souza B, Rowe M, Walls D (2000) The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus oncoprotein LMP-1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J Virol 74: 6652-6658
7. Eliopoulus A, Young L (2001) LMP-1 structure and signal transduction. Semin Cancer Biol 11: 435-444
8. Hahn P, Novikova E, Scherback L, Janik C, Pavlish O, Arkhipov V, Nicholls J, Müller-Lantzsch N, Gurtsevitch V, Grässer F (2001) The LMP-1 gene isolated from Russian Nasopharyngeal Carcinoma has no 30-bp deletion. Int J Cancer 91: 815-820
9. Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999) World Health Organization classification of neoplasic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849
10. Hayashi K, Chen WG, Chen YY, Bacchi M, Bacchi C, Alvarenga M, Abreu E, Chang K, Weiss L (1997) Deletion of Epstein-Barr virus latent membrane protein-1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion. Hum Pathol 28: 1408-1414
11. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson AB (1991) Induction of the bcl-2 expression by the Epstein-Barr virus Latent Membrane protein-1 protects infected B-cells from programmed cell death. Cell 65: 1107-1115
12. Hong S, Yoon W, Park J, Kang S, Ahn J, Lee T (2000) Involvement of two NF-κB binding elements in tumor necrosis factor alpha-, CD40-, and Epstein-Barr virus latent membrane protein-1 mediated induction of the cellular inhibitor of apoptosis protein 2 gene. J Biol Chem 275: 18022-18028
13. Hsu JL, Glaser S (2000) Epstein Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Clin Rev Hematol Oncol 34: 27-53
14. Izumi K, Kaye K, Kieff E (1994) Epstein-Barr virus recombinant molecular genetic analysis of the LMP-1 amino-terminal cytoplasmatic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. J Virol 68: 4369-4376
15. Jaffe E, Harris N, Diebold J, Muller-Hermelink H (1999) World Health Organization classification of neoplasic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol 111 Suppl 1: 8-12
16. Kaye KM, Izumi K, Kieff E (1993) Epstein-Barr virus latent membrane protein 1 is essential for B lymphocyte growth transformation. Proc Natl Acad Sci USA 90: 9150-9154
17. Knetch H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt B, Delsol G, Pallesen G (1993) Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82: 2937-2942
18. Knetch H, Bachmamm E, Joske D, Sahli R, Eméry-Goodman A, Casanova JL, Zilic M, Bachman F, Odermatt B (1993) Molecular analysis of the LMP-1 (Latent membrane protein) oncogene in Hodgkin's disease. Leukemia 7: 580-585
19. Knetch H, Berger C, Rothenberger S, Odrematt B, Brousset P (2001) The role of Epstein-Barr virus in neoplasic transformation. Oncology 60: 289-302
20. Knigma D, Weiss W, Jaffe E, Kumar S, Frekko K, Raffeld M (1996) Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in EBV-associated lymphoproliferative disorders and malignant lymphomas. Blood 88: 242-251
21. Laherty C, Hu H, Opipari A, Wang F, Dixit V (1992) The Epstein Barr virus LMP-1 product induces A20 zinc finger protein expression by activating nuclear factor-B. J Biol Chem 267: 24157-24160
22. Moorthy RK, Tholey-Lawson DA (1993) All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblast. J Virol 67: 1638-1646
23. Rickinson A, Kieff E (1996) Epstein Barr virus. In: Fields N, Knipe D (eds), Virology. Lippincott-Raven, Philadelphia, pp 2397-2446
24. Sambrook J, Russell D (2001) Preparation and analysis of eukaryotic genomic DNA. In: Molecular cloning: A laboratory manual. Cold Spring Harbor Press, New York, pp 6.4-6.11
25. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A (1990) Epstein Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B and EBNA-3C genes. J Virol 64: 4084-4092
26. Sandvej K, Peh S, Andresen B, Pallesen G (1994) Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus BNLF-1 gene in both malignant and benign EBV-associated diseases: High frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84: 4053-4060
27. Santon E, Manzanal A, Campo E, Bellas C (1995) Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol: Mol Pathol 48: M184
28. Shanmugaratnam K, Sobin L (1978) Histological typing of upper respiratory tract tumors. In: International Histological typing of tumors 19: 32-33, World Health Organization, Geneva, Switzerland
29. Smir B, Hauke R, Bierman P, Gross T, d'Amore F, Anderson J, Greiner T (1996) Molecular epidemiology of deletions and mutations of the latent membrane protein-1 oncogene of the Epstein-Barr virus in postransplant lymphoproliferative disorders. Lab Invest 75: 575-588
30. Trivedi P, Hu LF, Chen F, Chistensson B, Masucci M, Klein G, Winberg G (1994) Epstein-Barr virus (EBV)-encoded Membrane protein LMP-1 from a Nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Cancer 30A: 84-88
31. Walling D, Shebib N, Weaver S, Nichols C, Flaitz C, Webster-Cyriaque J (1999) The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J Infect Dis 179: 763-774
32. Wang D, Liebowitz D, Kieff E (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43: 831-840
33. Wang S, Rowe M, Lundgren E (1996) Expression of the Epstein-Barr virus transforming protein LMP-1 causes a rapid and transient stimulation of the bcl-2 homologue Mcl-1 levels in B cell lines. Cancer Res 56: 4610-4613
34. Wright D, Manos M (1990) Sample preparation from paraffin-embedded tissues. In: Innis M, Gelfand D, Sninsky J, White T (eds), PCR protocols. Academic Press Inc., Harcourt Brace